Latest AYLA reports update at 2023-03-31: 20222021
Ayala Pharmaceuticals logo
Ayala Pharmaceuticals AYLA
$ 0.5 0.0%

Ayala Pharmaceuticals Financial Statements 2011-2024 | AYLA

Annual Financial Statements Ayala Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

7.72 M 81.8 M 165 M - - - - - - - - -

Shares

15.4 M 14.4 M 12.7 M - - - - - - - - -

Historical Prices

0.5 5.68 13 - - - - - - - - -

Net Income

-38 M -40.3 M -30.1 M -17.8 M -8.87 M - - - - - - -

Revenue

692 K 3.51 M 3.71 M 2.33 M - - - - - - - -

Cost of Revenue

602 K 3.51 M 3.71 M 1.28 M - - - - - - - -

Gross Profit

90 K - - 1.05 M - - - - - - - -

Operating Income

-37.5 M -39.2 M -29.8 M -17.7 M - - - - - - - -

Interest Expense

- - - - - - - - - - - -

EBITDA

-37.3 M -39 M -29.6 M -17.6 M -8.99 M - - - - - - -

Operating Expenses

- - 29.8 M 18.8 M - - - - - - - -

General and Administrative Expenses

1.53 M 1.59 M 7.37 M 4.34 M 3.29 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Ayala Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 15.5 M 15.3 M 15.3 M 14 M 14.5 M 14.4 M 12.9 M 12.7 M 12.7 M 9.02 M 5 M 5 M 4.97 M 4.97 M 4.96 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- -10.2 M -8.21 M -10 M - -9.8 M -10.8 M -9.57 M - -7.44 M -6.71 M -6.6 M - -5.05 M -3.78 M -3.54 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- 91 K 38 K 458 K - 625 K 761 K 974 K - 658 K 1.04 M 1 M - 845 K 852 K 265 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- 91 K 38 K 368 K - 625 K 761 K 974 K - 658 K 1.04 M 1 M - 485 K 160 K 265 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- 90 K 90 K 90 K - - - - - - - - - 360 K 692 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- -10.1 M -7.84 M -9.85 M - -9.57 M -10.7 M -9.23 M - -7.28 M -6.61 M -6.44 M - -4.96 M -3.77 M -3.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- 63 K 16 K 5 K - - 7 K 3 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -9.96 M -7.76 M -9.82 M - -9.43 M -10.6 M -9.06 M - -7.14 M -6.52 M -6.39 M - -4.91 M -3.74 M -3.58 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - 9.94 M - - - 9.23 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- 2.88 M 2.26 M 2.44 M - 2.2 M 2.54 M 2.3 M - 1.86 M 1.55 M 1.31 M - 945 K 1.02 M 848 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency